(15 days)
No
The description focuses on semi-automatic contour detection and standard image processing techniques, with no mention of AI, ML, or related concepts.
No
The device is a software package that aids in the assessment of cardiac function and in determination of cardiovascular disease diagnosis and management. It does not directly treat or prevent a disease, but provides information for a trained physician to make therapeutic decisions.
Yes
The device aids in the "assessment of cardiac function and in determination of cardiovascular disease diagnosis and management" by calculating and displaying various cardiac functional parameters, which are then "interpreted by a trained physician" to facilitate diagnosis.
Yes
The device is described as a "software package" that runs on a workstation and performs image post-processing and analysis. There is no mention of accompanying hardware components that are part of the device itself.
Based on the provided information, this device is not an In Vitro Diagnostic (IVD).
Here's why:
- IVDs analyze biological samples: In Vitro Diagnostics are designed to examine specimens taken from the human body, such as blood, urine, tissue, etc., to provide information about a person's health.
- This device analyzes medical images: The CardIQ Function software processes and analyzes CT Cardiac images. These are images generated by a medical imaging modality, not biological samples.
- The intended use is image analysis for diagnosis and management: The software aids in the assessment of cardiac function and in the determination of cardiovascular disease diagnosis and management based on the analysis of these images.
Therefore, while this device is a medical device used for diagnosis and management, its function is based on the analysis of medical images rather than biological samples, which is the defining characteristic of an IVD.
N/A
Intended Use / Indications for Use
The CardIQ Function is a software package that can be used in conjunction with CT Cardiac images to (semi-automatically) calculate and display various Left Ventricular and Right Ventricular functional parameters such as End Systolic and End Diastolic Volumes, Stroke Volume, LV Ejection Fraction including Peak Filling and Ejection Rates, Myocardial Mass Calculations, Regional Wall Motion Display and Analysis. When interpreted by a trained physician, the software aids in assessment of cardiac function and in determination of cardiovascular disease diagnosis and management.
Product codes
90 JAK
Device Description
CardIQ Function, also called CT-MASS, is a software package for the GE advantage Windows (AW) workstation. CardIQ Function is an image post processing and analysis package that allows the user to obtain the clinical relevant anatomical and functional information from Cardiac CT images to facilitate cardiovascular disease diagnosis and risk management. In particular it supports:
- Ability to input, load and display multi-phase, multi-location Cardiac CT image series. Typically, these images are images along the short axis of the heart, reformatted from axial cardiac CT images.
- Display 3D or 4D image series as a function of either time variation within R-R period or locations along long and short axis.
- Manual or semi-automatic contour detection of either epicardium or endocardium edges of ventricular chambers.
- Measure and display ventricular wall motion, wall thickness, myocardium mass, ventricle volume and ejection fraction.
- Generating a patient/physician report, which contains cardiac function measurement data, sample source images and processed images.
Mentions image processing
Yes
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
CT Cardiac images
Anatomical Site
Cardiac/Heart (Left Ventricular and Right Ventricular)
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Trained physician
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Not Found
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1750 Computed tomography x-ray system.
(a)
Identification. A computed tomography x-ray system is a diagnostic x-ray system intended to produce cross-sectional images of the body by computer reconstruction of x-ray transmission data from the same axial plane taken at different angles. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.
0
Image /page/0/Picture/0 description: The image shows a black and white logo of General Electric (GE). The logo consists of the letters 'G' and 'E' intertwined within a circle. A small star is located to the upper left of the letters.
KOI 3422
P O Box 414 Milwaukee, WI 53201
510(k) SUMMARY OF SAFETY AND EFFECTIVENESS
This 510(k) summary of safety and effectiveness information is submitted in accordance with the requirements of 21 CFR Part 807.87(h).
Submitter Larry A. Kroger, Ph.D. Senior Regulatory Program Manager Telephone: (262) 544-3894, FAX: (262) 544-3863 Date Prepared: September 7, 2001
PRODUCT IDENTIFICATION
| Name: | CardIQ Function - |
|---|---|
| Classification Name: | Accessory to Computed Tomography System |
| Classification | |
| Number: | 892.1750 |
| Manufacturer : | General Electric Medical Systems |
| 3200 N. Grandview Blvd. | |
| Waukesha, WI 53188 | |
| Distributor: | General Electric Medical Systems, Milwaukee, WI |
| Marketed Devices | The CardIQ Function is substantially equivalent to the device listed below |
| Model: | |
| Manufacturer: | |
| 510(k) #: | Ventricular Analysis Toolkit Option |
| General Electric Medical Systems, Milwaukee, WI | |
| K000315 |
Device Description:
CardIQ Function, also called CT-MASS, is a software package for the GE advantage Windows (AW) workstation. CardIQ Function is an image post processing and analysis package that allows the user to obtain the clinical relevant anatomical and functional information from Cardiac CT images to facilitate cardiovascular disease diagnosis and risk management. In particular it supports:
- Ability to input, load and display multi-phase, multi-location Cardiac CT image series. . Typically, these images are images along the short axis of the heart, reformatted from axial cardiac CT images.
- Display 3D or 4D image series as a function of either time variation within R-R period or ● locations along long and short axis.
1
- Manual or semi-automatic contour detection of either epicardium or endocardium edges of . ventricular chambers.
- Measure and display ventricular wall motion, wall thickness, myocardium mass, ventricle . volume and ejection fraction.
- Generating a patient/physician report, which contains cardiac function measurement data, . sample source images and processed images.
Indications for Use :
The CardIQ Function is a software package that can be used in conjunction with CT Cardiac images to (semi-automatically) calculate and display various Left Ventricular and Right Ventricular functional parameters such as End Systolic and End Diastolic Volumes, Stroke Volume, LV Ejection Fraction including Peak Filling and Ejection Rates, Myocardial Mass Calculations, Regional Wall Motion Display and Analysis. When interpreted by a trained physician, the software aids in assessment of cardiac function and in determination of cardiovascular disease diagnosis and management.
Comparison with Predicate:
CardIQ Function is an image post processing and analysis package that allows the user to obtain the clinically relevant anatomical and functional information from Cardiac CT images. This application is a natural extension to the MR Ventricular Analysis Toolkit, which now supports the processing of cardiac images from CT imaging devices.
| ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
. |
:
Viimher
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | |
|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--|
|
and and and other the contraction of the closed and the distribution and the distribution and the desimble of the desimilation and the desimilation the comments of the desimi
.
.
ANALA PARK COMES A
99/1/010
10/11/11/1
STOLOID | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ | |
Adverse Effects on Health :
The potential hazards are identified in a risk management summary (hazard analysis) and are controlled by:
- · Software Development. Validation and Verification Process to ensure performance to specifications, Federal Regulations and user requirements.
- · Adherence to industry and international standards.
Conclusions:
The CardIQ Function does not result in any new potential safety risks and performs as well as devices currently on the market. GE considers features of the CardIQ Function to be equivalent to those of Ventricular Analysis Toolkit Option (K000315).
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health and Human Services (HHS). The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
OCT 3 0 2001
General Electric Medical Systems % Mr. Reiner Krumme Manager, Medical Division TUV Rheinland of North America 12 Commerce Road NEWTON CT 06470
Re: K013422
Trade/Device Name: CardIQ Function Regulation Number: 21 CFR 892.1750 Regulation Name: Computed tomography x-ray system Regulatory Class: II
Product Code: 90 JAK Dated: October 9, 2001 Received: October 16, 2001
Dear Mr. Krumme:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (sections 531-542 of the Act); 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at one of the following numbers, based on the regulation number at the top of this letter:
| 8xx.1xxx | (301) 594-4591 |
|---|---|
| 876.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4616 |
| 884.2xxx, 3xxx, 4xxx, 5xxx, 6xxx | (301) 594-4616 |
| 892.2xxx, 3xxx, 4xxx, 5xxx | (301) 594-4654 |
| Other | (301) 594-4692 |
Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsmaldsmamain.html.
Sincerely yours,
Nancy C. Brogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
510(k) Number (if known):
Device Name: CardIQ Function
Indications for Use
The CardIQ Function is a software package that can be used in conjunction with CT Cardiac images to (semi-automatically) calculate and display various Left Ventricular and Right Intricular functional parameters such as End Systolic and End Diastolic Volumes, Stroke Vchume, LV Ejection Fraction including Peak Filling and Ejection Rates, Myocardial Mass Volume, E. Ejocion Fraction Roll More Display and Analysis. When interpreted by a trained Oblouition, the software aids in assessment of cardiac function and in determination of cardiovascular disease diagnosis and management.
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
(Per 21 CFR 801-109)
OR Over-The-Counter Use___
Concurrence of CDRH, Office of Device Evaluation (ODE)
David G. Severson
Division of Reproduction, Abdominal, and Radiological Devices
510(k) Number K013422